Pfizer stands high
Source: Agencies |
August 16, 2011, Tuesday
|
Print Edition
Print Edition
PFIZER Inc yesterday said it won a patent infringement case against the United States unit of Teva Pharmaceuticals Industries Ltd, preventing Teva from launching a generic version of Pfizer's erectile dysfunction drug Viagra until October 2019.
Pfizer, the world's biggest drugmaker, said litigation on the same patent remains pending against other generic companies, but no trials are scheduled in those cases.
Pfizer, the world's biggest drugmaker, said litigation on the same patent remains pending against other generic companies, but no trials are scheduled in those cases.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
